These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 37372128)
1. Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions. Salomão R; Assis V; de Sousa Neto IV; Petriz B; Babault N; Durigan JLQ; de Cássia Marqueti R Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372128 [TBL] [Abstract][Full Text] [Related]
2. Plasma Levels of MMPs and TIMP-1 in Patients with Osteoarthritis After Recovery from COVID-19. Tuharov Y; Krenytska D; Halenova T; Kot L; Raksha N; Savchuk O; Prysiazhniuk L; Matkivska R; Falalyeyeva T; Ostapchenko L Rev Recent Clin Trials; 2023; 18(2):123-128. PubMed ID: 37231778 [TBL] [Abstract][Full Text] [Related]
3. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review. Kaur S; White S; Bartold M JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156 [TBL] [Abstract][Full Text] [Related]
4. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases. Kim IS; Yang WS; Kim CH Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Gueders MM; Foidart JM; Noel A; Cataldo DD Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. Mohammadhosayni M; Sadat Mohammadi F; Ezzatifar F; Mahdavi Gorabi A; Khosrojerdi A; Aslani S; Hemmatzadeh M; Yazdani S; Arabi M; Marofi F; Jadidi-Niaragh F; Shomali N; Mohammadi H Int Immunopharmacol; 2021 Nov; 100():108076. PubMed ID: 34450402 [TBL] [Abstract][Full Text] [Related]
7. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects. Levin M; Udi Y; Solomonov I; Sagi I Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874 [TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress. da Silva-Neto PV; do Valle VB; Fuzo CA; Fernandes TM; Toro DM; Fraga-Silva TFC; Basile PA; de Carvalho JCS; Pimentel VE; Pérez MM; Oliveira CNS; Rodrigues LC; Bastos VAF; Tella SOC; Martins RB; Degiovani AM; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; Rocha JJRD; Feres O; Arruda E; Maruyama SR; Russo EMS; Viana AL; Santos IKFM; Bonato VLD; Cardoso CRB; Tanus-Santos JE; Donadi EA; Faccioli LH; Dias-Baruffi M; Fernandes APM; Gerlach RF; Sorgi CA; On Behalf Of The Immunocovid Study Group Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625532 [TBL] [Abstract][Full Text] [Related]
9. Regulation of matrix metalloproteinases: an overview. Chakraborti S; Mandal M; Das S; Mandal A; Chakraborti T Mol Cell Biochem; 2003 Nov; 253(1-2):269-85. PubMed ID: 14619979 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. Benjamin MM; Khalil RA Exp Suppl; 2012; 103():209-79. PubMed ID: 22642194 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in arthritis: towards precision medicine. Grillet B; Pereira RVS; Van Damme J; Abu El-Asrar A; Proost P; Opdenakker G Nat Rev Rheumatol; 2023 Jun; 19(6):363-377. PubMed ID: 37161083 [TBL] [Abstract][Full Text] [Related]
12. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463 [TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. He L; Kang Q; Chan KI; Zhang Y; Zhong Z; Tan W Front Immunol; 2022; 13():1093990. PubMed ID: 36776395 [TBL] [Abstract][Full Text] [Related]
14. Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection. Shukla V; Shakya AK; Shukla M; Kumari N; Krishnani N; Dhole TN; Misra UK Virusdisease; 2016 Mar; 27(1):63-76. PubMed ID: 26925446 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update. Florczak-Rzepka M; Grond-Ginsbach C; Montaner J; Steiner T Cerebrovasc Dis; 2012; 34(4):249-62. PubMed ID: 23052179 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases (MMPs) in health and disease: an overview. Malemud CJ Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Spinale FG Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815 [TBL] [Abstract][Full Text] [Related]
18. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae. Ramírez-Martínez G; Jiménez-Álvarez LA; Cruz-Lagunas A; Ignacio-Cortés S; Gómez-García IA; Rodríguez-Reyna TS; Choreño-Parra JA; Zúñiga J J Interferon Cytokine Res; 2022 Aug; 42(8):352-368. PubMed ID: 35647937 [TBL] [Abstract][Full Text] [Related]
19. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
20. MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. D Avila-Mesquita C; Couto AES; Campos LCB; Vasconcelos TF; Michelon-Barbosa J; Corsi CAC; Mestriner F; Petroski-Moraes BC; Garbellini-Diab MJ; Couto DMS; Jordani MC; Ferro D; Sbragia L; Joviliano EE; Evora PR; Carvalho Santana R; Martins-Filho OA; Polonis K; Menegueti MG; Ribeiro MS; Auxiliadora-Martins M; Becari C Biomed Pharmacother; 2021 Oct; 142():112067. PubMed ID: 34449310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]